22
’
Intraarterial Lidocaine for Pain Control in UAE
Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011; 63(Suppl 11):S240–S252. 18. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001; 8:1153–1157. 19. Pereira J, Bruera E. Alberta Hospice Palliative Care Manual. 2nd edition. Calgary, AB: Alberta Cancer Board, 2001; 75. 20. Kim HS, Czuczman GJ, Nicholson WK, Pham LD, Richman JM. Pain levels within 24 hours after UFE: a comparison of morphine and fentanyl patient-controlled analgesia. Cardiovasc Intervent Radiol 2008; 31: 1100–1107.
Noel-Lamy et al
’
JVIR
21. Ruuskanen A, Sipola P, Hippeläinen M, Wüstefeld M, Manninen H. Pain after uterine fibroid embolisation is associated with the severity of myometrial ischaemia on magnetic resonance imaging. Eur Radiol 2009; 19:2977–2985. 22. Keyoung JA, Levy EB, Roth AR, et al. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. J Vasc Interv Radiol 2001; 12:1065–1073. 23. Zhan S, Li Y, Wang G, Han H, Yang Z. Effectiveness of intra-arterial anesthesia for uterine fibroid embolization using dilute lidocaine. Eur Radiol 2005; 15:1752–1756.
CME TEST QUESTIONS: JANUARY 2017
Examination available at http://learn.sirweb.org/. To take the online JVIR CME tests, please log into the SIR Learning Center with your SIR user name and password. Nonmembers: If you do not already have an SIR username and password, please click on “Create an Account” to gain access to the SIR Learning Center. Once in the Learning Center, click on the “Publication” activity type for a listing of all available JVIR CME tests. Each test will be available online for 3 years from the month/date of publication. The CME questions in this issue are derived from the article “Intraarterial Lidocaine for Pain Control in Uterine Artery Embolization: A Prospective, Randomized Study” by Noel-Lamy et al. 1. The commonest challenge in managing patients after uterine fibroid embolization (UFE) is a. Nausea b. Dull abdominal and back pain c. Severe cramping pelvic pain d. Vaginal bleeding 2. In this study, the level of pain reported at 4 hours following uterine fibroid embolization was significantly lower in which group? a. Group A only; Lidocaine during embolization. b. Group B only; Lidocaine after the embolization endpoint reached. c. Group C only; Control group i.e. lidocaine not injected. d. Group A and B but not group C. e. The pain reported in all three groups was approximately the same. 3. In this study, the level of pain reported at 7 hours following uterine fibroid embolization was significantly lower in which group? a. Group A only; lidocaine during embolization. b. Group B only; lidocaine after the embolization endpoint reached.
c. Group C only; control group i.e. lidocaine not injected. d. Group A and B but not group C. e. The pain reported in all three groups was approximately the same. 4. True or False: While pain at the time of discharge was about the same for all three groups, the amount of intravenous narcotic medications administered during the hospitalization was considerably higher in the groups that used intra-arterial lidocaine. a. True b. False 5. In this study, approximately what percentage of patients in Group A (lidocaine during embolization) demonstrated complete fibroid infarction by imaging criteria on their 3-month follow-up MRI? a. 20% b. 40% c. 60% d. 80%